CTNND2 (δ-catenin) was suggested as a potential cancer biomarker and was associated with the expression of markers of cancer stem cells in lung adenocarcinoma (Lu et al., 2014; Huang et al., 2018). This evidence concerns the gene CTNND2 and lung adenocarcinoma.